Your browser doesn't support javascript.
COVID-19 Vaccination Intentions, Concerns, and Facilitators Among US Parents of Children Ages 6 Months Through 4 Years.
Scherer, Aaron M; Gidengil, Courtney A; Gedlinske, Amber M; Parker, Andrew M; Askelson, Natoshia M; Woodworth, Kate R; Petersen, Christine A; Lindley, Megan C.
  • Scherer AM; Department of Internal Medicine, University of Iowa, Iowa City.
  • Gidengil CA; RAND Corporation, Boston, Massachusetts.
  • Gedlinske AM; Division of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Parker AM; Department of Internal Medicine, University of Iowa, Iowa City.
  • Askelson NM; RAND Corporation, Piitsburgh, Pennsylvania.
  • Woodworth KR; Department of Community and Behavioral Health, University of Iowa, Iowa City.
  • Petersen CA; Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia.
  • Lindley MC; Department of Internal Medicine, University of Iowa, Iowa City.
JAMA Netw Open ; 5(8): e2227437, 2022 08 01.
Article in English | MEDLINE | ID: covidwho-1971189
ABSTRACT
Importance Children aged 6 months through 4 years have become eligible for COVID-19 vaccination, but little is known about parental intentions regarding, concerns about, or facilitators to COVID-19 vaccination for this age group.

Objectives:

To evaluate parental intentions, concerns, and facilitators for COVID-19 vaccination for children aged 6 months through 4 years and to help inform the US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices' deliberations and recommendations for COVID-19 vaccination for children aged 6 months through 4 years. Design, Setting, and

Participants:

This cross-sectional study fielded an online survey from February 2 to 10, 2022, among a nonprobability sample of US parents of children aged 6 months through 4 years who were recruited through Qualtrics using quota-based sampling for respondent gender, race and ethnicity, and child age group. Main Outcomes and

Measures:

COVID-19 vaccination intentions, time to COVID-19 vaccination, COVID-19 vaccination concerns and facilitators, and trusted COVID-19 vaccination locations for children aged 6 months through 4 years.

Results:

The final weighted sample of 2031 participants (73.5% participation rate) had more respondents who identified as male (985; weighted percentage, 54.8%) or White (696; weighted percentage, 66.2%), were aged 25 to 49 years (1628; weighted percentage, 85.6%), had at least a bachelor's degree (711; weighted percentage, 40.0%), lived in a metropolitan area (1743; weighted percentage, 82.9%) or the South (961; weighted percentage, 43.4%), or received at least 1 dose of a COVID-19 vaccine (1205; weighted percentage, 59.8%). Half of respondents (645; weighted percentage, 45.6%) indicated that they "definitely" or "probably" will vaccinate their child aged 6 months through 4 years once they became eligible. However, only one-fifth (396; weighted percentage, 19.0%) indicated they would get a COVID-19 vaccine for their child in this age group within 3 months of them becoming eligible for vaccination. Vaccine safety and efficacy were parents' top concerns, and receiving more information about safety and efficacy were the top facilitators to COVID-19 vaccination for this age group. A doctor's office or clinic and local pharmacy were the most trusted COVID-19 vaccination locations for this age group. Conclusions and Relevance These results suggest that only a minority of parents of children in this age group are eager to vaccinate their children within the first few months of eligibility, with widespread concerns about COVID-19 vaccination for this age group. Thus, considerable efforts to increase parental COVID-19 vaccine confidence for children aged 6 months through 4 years may be needed to maximize COVID-19 vaccination for this age group in the United States.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Adult / Child / Humans / Male / Young adult Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Adult / Child / Humans / Male / Young adult Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article